temozolomide has been researched along with zstk474 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, W; Kong, D; Shao, J; Wang, R; Xu, Y; Zhang, X; Zhang, Y; Zhong, Y; Zhu, S | 1 |
1 other study(ies) available for temozolomide and zstk474
| Article | Year |
|---|---|
ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; DNA Repair; Drug Resistance, Neoplasm; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Recombinational DNA Repair; Temozolomide; Triazines; Xenograft Model Antitumor Assays | 2022 |